SynthesisFrontiers in immunology2023

Treatment-free survival after discontinuation of immune checkpoint inhibitors in mNSCLC: a systematic review and meta-analysis.

Yue Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.